All CoverageBusiness & PolicyEOM, Value-Based Oncology Pose ChallengesLalan Wilfong, MDVideoLalan Wilfong, MD, details some of the biggest challenges associated with EOM in specific and value-based oncology care in general. Business & PolicyEOM, Value-Based Oncology Pose ChallengesLalan Wilfong, MDVideoLalan Wilfong, MD, details some of the biggest challenges associated with EOM in specific and value-based oncology care in general. Business & PolicyPBMs and 340B Abuse: Key “Fights” in OncologyMiriam J. Atkins, MDVideoMiriam J. Atkins, MD, president of COA, explains how focusing on PBMs, 340B abuse, and vertical integration is making a difference for community oncologists. Business & PolicyPBMs and 340B Abuse: Key “Fights” in OncologyMiriam J. Atkins, MDVideoMiriam J. Atkins, MD, president of COA, explains how focusing on PBMs, 340B abuse, and vertical integration is making a difference for community oncologists. Business & Policy"Ridiculous" Policy Changes Harm OncologistsBen JonesVideoBen Jones, VP of government relations and public policy at The US Oncology Network, explains policy changes that may "significantly disrupt" community oncology. Business & Policy"Ridiculous" Policy Changes Harm OncologistsBen JonesVideoBen Jones, VP of government relations and public policy at The US Oncology Network, explains policy changes that may "significantly disrupt" community oncology. Business & PolicyNew Career Path for Innovative Oncologists?Stephen Schleicher, MD, MBAVideoOncologists interested in healthcare innovation often choose between clinical practice and leaving medicine to pursue business. A new option may change that. Business & PolicyNew Career Path for Innovative Oncologists?Stephen Schleicher, MD, MBAVideoOncologists interested in healthcare innovation often choose between clinical practice and leaving medicine to pursue business. A new option may change that. Business & PolicyOncologist Shortage Looms: "Huge Gap" PossibleDavey B. Daniel, MDVideo"The shortage of the oncology workforce is real," says Davey B. Daniel, MD. "At any time, we can actually have a huge gap" in the amount of oncologists needed. Business & PolicyOncologist Shortage Looms: "Huge Gap" PossibleDavey B. Daniel, MDVideo"The shortage of the oncology workforce is real," says Davey B. Daniel, MD. "At any time, we can actually have a huge gap" in the amount of oncologists needed. Business & PolicyEthical Questions in Value-Based Oncology CareStephen “Fred” Divers, MDVideoWhen it comes to value-based oncology, “I don’t think anybody wants to play God and decide who does and doesn’t receive care,” says Stephen “Fred” Divers, MD. Business & PolicyEthical Questions in Value-Based Oncology CareStephen “Fred” Divers, MDVideoWhen it comes to value-based oncology, “I don’t think anybody wants to play God and decide who does and doesn’t receive care,” says Stephen “Fred” Divers, MD. Business & PolicyAre Community Oncology Collaborations Worth It?Jeffrey Vacirca, MDVideo"I think there's always going to be some degree of antagonism between hospital-based practices and community-based practices," explains Jeffrey Vacirca, MD. Business & PolicyAre Community Oncology Collaborations Worth It?Jeffrey Vacirca, MDVideo"I think there's always going to be some degree of antagonism between hospital-based practices and community-based practices," explains Jeffrey Vacirca, MD. Policy and ValueCommunity Oncologists Must "Show Up" for AdvocacyDebra Patt, MD, PhD, MBAVideoWhen it comes to changing policies detrimental to community oncology, doctors can make a difference "simply by showing up," says Debra Patt, MD, PhD, MBA. Policy and ValueCommunity Oncologists Must "Show Up" for AdvocacyDebra Patt, MD, PhD, MBAVideoWhen it comes to changing policies detrimental to community oncology, doctors can make a difference "simply by showing up," says Debra Patt, MD, PhD, MBA. Business & Policy“You Can’t Just Be an Oncologist,” Says COA LeaderTed OkonVideoLegal concerns over cancer drug delivery and growing costs associated with PBMs mean “you can’t just be an oncologist,” says Ted Okon, executive director of COA. Business & Policy“You Can’t Just Be an Oncologist,” Says COA LeaderTed OkonVideoLegal concerns over cancer drug delivery and growing costs associated with PBMs mean “you can’t just be an oncologist,” says Ted Okon, executive director of COA. Business & PolicyOncology Leader Calls for Antitrust ProbeBarbara L. McAneny, MDVideoBarbara L. McAneny, MD, discusses “a serious problem that the FTC or DOJ needs to look into” as well as practice management concerns at this year’s COA conference. Business & PolicyOncology Leader Calls for Antitrust ProbeBarbara L. McAneny, MDVideoBarbara L. McAneny, MD, discusses “a serious problem that the FTC or DOJ needs to look into” as well as practice management concerns at this year’s COA conference. Breast Cancer“Big Question Marks” About ADC Sequencing in MBCManali Bhave, MD; Stephanie Graff, MD; Erin Frances Cobain, MDVideoWithout clear data to guide them, our panel discusses how they currently handle concerns related to ADC sequencing in metastatic breast cancer. Breast Cancer“Big Question Marks” About ADC Sequencing in MBCManali Bhave, MD; Stephanie Graff, MD; Erin Frances Cobain, MDVideoWithout clear data to guide them, our panel discusses how they currently handle concerns related to ADC sequencing in metastatic breast cancer. Endometrial and Uterine CancersKey Endometrial Cancer Data From SGO 2024Ursula A. Matulonis, MDVideoUrsula A. Matulonis, MD, breaks down results from the pivotal RUBY and NRG GY018 trials, which she says are “very much practice-changing.” Endometrial and Uterine CancersKey Endometrial Cancer Data From SGO 2024Ursula A. Matulonis, MDVideoUrsula A. Matulonis, MD, breaks down results from the pivotal RUBY and NRG GY018 trials, which she says are “very much practice-changing.”